Molecular Pharming Market Size is valued at USD 1655.3 Mn in 2023 and is predicted to reach USD 3516.73 Mn by the year 2034 at a 8.1% CAGR during the forecast period for 2025-2034.
In a biotechnological program known as "molecular farming," crops are genetically altered to create proteins and chemicals for industrial and pharmaceutical uses. The vast majority of developing nations cannot pay the enormous price of medical treatments brought on by the already-used techniques. Farmers are urged by mounting environmental concerns to reorient their efforts toward sustainable agriculture methods, including resource conservation. This has increased the demand for better crop nutrition and protection, supporting market expansion.
The molecular farming market growth is also anticipated to continue growing due to the rising demand for modern medicines and pharmaceuticals. Increasing environmental concerns are pressuring farmers to refocus their efforts on sustainable agriculture practices, including resource conservation. As a result, there is a tremendous need for improved crop nutrition and protection, which has helped the molecular farming industry to grow.
The molecular pharming market is segmented on the crop type, technology, applications and end users. The market is segmented based on crop type: maize, barley, tobacco, safflower, rice and alfalfa. Based on technology, the molecular pharming market is segmented into gene guns, agroinfiltration, electroporation, agrobacterium-mediated gene transfer and Others. Based on the application, the molecular pharming market is segmented into recombinant antibodies, hormones, vaccines, industrial enzymes, proteins & protein-based materials, technical reagents, and nutritional products. Based on end-use, the molecular pharming market is segmented into biotechnology & pharmaceutical companies, contract manufacturing organizations, and others.
The market's leading segment is gene guns. A gene gun is a tool that is used to transport external (exogenous) DNA, RNA, or proteins to the cells in a way that allows the biological particles to be reproduced or translated using the plant reproduction system and to multiply the necessary biologics without the need of low-cost microbial systems.
The process known as agroinfiltration combines plant biotechnology and agriculture. To mass-create the desired protein, the approach simultaneously stimulates transitory gene expression in a plant, part of a plant, or numerous plants. A microbiological technique called electroporation, also referred to as electro-permeabilization, employs an electric field to make cells more permeable via their membranes. When utilized in plant biotechnology, these cells are preferably plant cells.
Biotechnology & pharmaceutical companies grabbed the highest revenue share, and it is anticipated that they will continue to hold that position during the anticipated time. Strong government support for the market is demonstrated by programs aiming to modernize the regulatory environment, enhance approval procedures and reimbursement practices, and standardize clinical studies. Biotechnological methods are expanding significantly, with examples including genetic engineering, DNA fingerprinting, and stem cell technologies.
The North American molecular pharming market is expected to register the highest market share in revenue shortly. The region's market has a high revenue due to factors including expanding government efforts that boost the implementation of modern agriculture technologies and established infrastructure. Additionally, a robust administrative framework helps farmers acquire the necessary skills for using and maintaining molecular farming equipment.
In addition, Asia Pacific is projected to grow rapidly in the global molecular pharming market. In emerging nations like India, Sri Lanka, and Nigeria, various government programs are being carried out to promote the adoption of cutting-edge molecular farming technologies and consequently increase productivity.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 1655.3 Mn |
|
Revenue Forecast In 2034 |
USD 3516.73 Mn |
|
Growth Rate CAGR |
CAGR of 8.1% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Crop Type, Technology, Applications And End Users |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Leaf Expression Systems, ORF Genetics hf., Agrenvec S.L., PlantForm, Protalix Biotherapeutics, Kbio, Inc., Cape Biologix Technologies (Cape Bio Pharms), Bright Biotech, Moolec Science SA, Miruku, Tiamat Sciences Corp., IngredientWerks, Core Biogenesis, Diamante Società Benefit S.r.l., Elo Life Systems, G+FLAS Life Sciences, Inc., BIOBETTER, MOZZA FOODS, FORTE PROTEIN INC., KYOMEI, NOBELL FOODS, PIGMENTUM, MNPHARM, Finally Foods, Tiamat Sciences, POLOPO Ltd., VELOZBIO, newmoo Foods, BionFarming GmbH and Other Market Players |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Molecular Pharming Market Snapshot
Chapter 4. Global Molecular Pharming Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Technology Estimates & Trend Analysis
5.1. by Technology & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Technology:
5.2.1. Gene Gun
5.2.2. Agroinfiltration
5.2.3. Electroporation
5.2.4. Agrobacterium-Mediated Gene Transfer
5.2.5. Others
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
6.2.1. Recombinant Antibodies
6.2.2. Hormones
6.2.3. Vaccines
6.2.4. Industrial Enzymes
6.2.5. Proteins & Protein-Based Materials
6.2.6. Technical Reagents
6.2.7. Nutritional Products
6.2.8. Others
Chapter 7. Market Segmentation 3: by Crop Source Estimates & Trend Analysis
7.1. by Crop Source & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Crop Source:
7.2.1. Maize
7.2.2. Barley
7.2.3. Tobacco
7.2.4. Safflower
7.2.5. Rice
7.2.6. Alfalfa
Chapter 8. Market Segmentation 4: by End-user Estimates & Trend Analysis
8.1. by End-user & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-user:
8.2.1. Biotechnology & Pharmaceutical Companies
8.2.2. Contract Manufacturing Organizations
8.2.3. Others
Chapter 9. Molecular Pharming Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.1.2. North America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.1.3. North America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Crop Source, 2021-2034
9.1.4. North America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.1.5. North America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.2.2. Europe Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.2.3. Europe Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Crop Source, 2021-2034
9.2.4. Europe Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.2.5. Europe Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.3.2. Asia Pacific Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.3.3. Asia-Pacific Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Crop Source, 2021-2034
9.3.4. Asia-Pacific Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.3.5. Asia Pacific Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.4.2. Latin America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.4.3. Latin America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Crop Source, 2021-2034
9.4.4. Latin America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.4.5. Latin America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.5.2. Middle East & Africa Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.5.3. Middle East & Africa Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Crop Source, 2021-2034
9.5.4. Middle East & Africa Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.5.5. Middle East & Africa Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Agrenvec S.L
10.2.2. Bright Biotech
10.2.3. Core Biogenesis
10.2.4. Diamante SRL
10.2.5. Leaf Systems International Limited
10.2.6. Medicago Inc
10.2.7. Meristem Therapeutics S.A. (Ventria Bioscience)
10.2.8. Miruku
10.2.9. Moolec Science Limited
10.2.10. mozza
10.2.11. Nobell Foods
10.2.12. ORF Genetics
10.2.13. Pfizer, Inc.
10.2.14. ProdiGene Inc
10.2.15. Protalix Biotherapeutics, Inc
10.2.16. Tiamat Sciences
10.2.17. Other Prominent Players
Molecular Pharming Market, By Crop Source:
Molecular Pharming Market, By Technology:
Molecular Pharming Market, By Application:
Molecular Pharming Market, By End User:
Molecular Pharming Market, By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
